Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levonorgestrel intrauterine device versus pentoxifylline for symptomatic adenomyosis
ACTRN12617001021369Phase 3Recruiting
- Sponsor
- Nahed Allam
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of avatrombopag and pentoxifylline in adenomyosis (2 arms), sponsored by Nahed Allam. Primary endpoints: Dysmenorrhea pain and Chronic pelvic pain. Started Sep 2018; status: recruiting.
02
Drugs
avatrombopagpentoxifylline
03
Conditions
adenomyosis
Beyond the preview
Go deeper on ACTRN12617001021369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001021369.